RxDoctor Payments Data

James Miller, MD

Family Medicine · North Mankato, MNNPI 1013995042

Payments from drug & device makers

$1,837in general payments, 2019–2025

Across 18 payments — averaging $102.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Amgen$29
  • Pfizer$28
  • Ironshore Pharmaceuticals Inc.$24
  • Harmony Biosciences LLC$19
  • Novo Nordisk$17
  • plus $57 from 4 others

What the payments were for

  • Travel & lodging$1,32472%
  • Food & beverage$51228%

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,837 in reported general payments places this provider in the 90th percentile of 1,162 family medicine providers in Minnesota.

See all family medicine providers in Minnesota

Medicare billing

Part B allowed, 2024
$151,997
Medicare patients
313
Services billed
3,691

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin94$141,630
EliquisApixaban93$87,584
MounjaroTirzepatide45$66,631
OzempicSemaglutide35$60,195
TrulicityDulaglutide39$59,491
XareltoRivaroxaban39$37,591
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$23,921
Incruse ElliptaUmeclidinium Bromide37$21,332
FarxigaDapagliflozin Propanediol15$14,424
RybelsusSemaglutide13$13,022
Breo ElliptaFluticasone/Vilanterol20$12,947
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog19$12,042
Humalog Kwikpen U-100Insulin Lispro23$12,003
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr20$10,612
Lantus SolostarInsulin Glargine,hum.Rec.Anlog57$9,821

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$28$87,58493 claims
Novo NordiskOzempic, Rybelsus$17$73,21748 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,162 family medicine providers in Minnesota.

Other family medicine in North Mankato

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →